Press Releases 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Eagle Pharmaceuticals Commences Pivotal Study for Fulvestrant 12/7/17 Eagle Pharmaceuticals, Inc. to Present at 29th Annual Piper Jaffray Healthcare Conference 11/20/17 Eagle Pharmaceuticals, Inc. Reports Third Quarter 2017 Results 11/8/17 Eagle Pharmaceuticals, Inc. to Present at Jefferies 2017 London Healthcare Conference 11/7/17 Eagle Pharmaceuticals, Inc. to Discuss Third Quarter 2017 Financial Results on November 8, 2017 10/30/17 Eagle Pharmaceuticals Receives Tentative FDA Approval for PEMFEXY (Pemetrexed Injection) Ready-to-Dilute 10/27/17 Eagle Pharmaceuticals Announces New Patent for RYANODEX 10/17/17 Eagle Pharmaceuticals Licenses Japanese Rights for Bendamustine Hydrochloride Ready-to-dilute and Rapid Infusion Injection Products to SymBio Pharmaceuticals Limited 9/20/17 Eagle Pharmaceuticals, Inc. to Present at September Investor Conferences 9/6/17 Eagle Pharmaceuticals Announces Positive Results of Study Conducted to Evaluate Neuroprotective Effects of RYANODEX Secondary to Nerve Agent Exposure 9/5/17 Pagination Current page 1 Page 2 Page 3 Page 4 Next page Last page
